Use of Injectable Extended Platelet-Rich Fibrin as a Local Drug Delivery in the Treatment of Stage II Periodontitis Patients

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

May 7, 2025

Study Completion Date

June 17, 2025

Conditions
Periodontitis Stage IIGingival Pocket
Interventions
OTHER

extended platelet rich fibrin injection in pocket

Whole blood (10 mL) will be centrifuged at 700 g for 8 minutes. The upper layer (yellow layer) shows the liquid plasma layer. The most upper layer of platelet- poor plasma (PPP) will be collected in a syringe. then PPP will be heated in a heat block device at 75°C for 10 minutes and thereafter cooled to room temperature for approximately 2 minutes. An injectable albumin gel will then be prepared. Then the liquid platelet-rich layer (liquid-PRF) including the buffy coat layer with accumulated platelets and leukocytes, will be collected in a separate syringe. The albumin gel and native liquid PRF will then be thoroughly mixed by utilizing a female-female luer lock connector. Now injectable e-PRF in final form is ready to be used.

OTHER

albumin injection in pocket

Whole blood (10 mL) will be centrifuged at 700 g for 8 minutes. The upper layer (yellow layer) shows the liquid plasma layer. The most upper layer of platelet- poor plasma (PPP) will be collected in a syringe. then PPP will be heated in a heat block device at 75°C for 10 minutes and thereafter cooled to room temperature for approximately 2 minutes. An injectable albumin gel will then be prepared.

OTHER

scaling and root planing

removes plaque and calculus above and below the gumline using manual or ultrasonic instruments.

Trial Locations (1)

35516

Mansoura university, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT07080294 - Use of Injectable Extended Platelet-Rich Fibrin as a Local Drug Delivery in the Treatment of Stage II Periodontitis Patients | Biotech Hunter | Biotech Hunter